Literature DB >> 23565611

Characteristics of intrahepatic cholangiocarcinoma in patients with hepatitis B virus infection: clinicopathologic study of resected tumours.

Z-F Wu1, N Yang, D-Y Li, H-B Zhang, G-S Yang.   

Abstract

Recent efforts suggest an aetiological role of hepatitis B virus (HBV) infection in intrahepatic cholangiocarcinoma (ICC). The purpose of this study was to clarify the clinicopathologic characteristics and surgical outcomes of patients with HBV-associated ICC. All patients with chronic HBV infection were identified from a database of patients with ICC that underwent surgical resection between 1 January 2005 and 31 December 2006. Their clinicopathologic and survival characteristics were compared with ICC patients without chronic HBV infection. The age of the HBV-associated ICC patients tend to be younger than that of ICC patients without chronic HBV infection. HBV-associated ICC patients tend to have higher abnormal α-fetoprotein levels and lower abnormal serum carbohydrate antigen19-9 (CA19-9), r-glutamyltransferase (r-GT) and alkaline phosphatase levels. The pathologic features of the resected specimens revealed that HBV-associated ICC patients tended to be of the mass-forming type have a lower prevalence of lymphatic involvement and poorer tumour differentiation, and a higher prevalence of capsule formation and liver cirrhosis. Patients with HBV-associated ICC had a significantly better survival than patients without chronic HBV infection. The clinicopathological features of HBV-associated ICC patients showed significant differences from ICC patients without HBV infection. These tumours are characterized by the mass-forming growth pattern and appeared to have a more favourable prognosis.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23565611     DOI: 10.1111/jvh.12005

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  15 in total

1.  A simple and effective prognostic staging system based on clinicopathologic features of intrahepatic cholangiocarcinoma.

Authors:  Huabang Zhou; Xiaolan Jiang; Qiaomei Li; Jingyi Hu; Zhengrong Zhong; Hao Wang; Hui Wang; Bing Yang; Heping Hu
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

Review 2.  Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis.

Authors:  Shun-ichi Ariizumi; Masakazu Yamamoto
Journal:  Surg Today       Date:  2014-09-25       Impact factor: 2.549

Review 3.  Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis.

Authors:  Seogsong Jeong; Guijuan Luo; Zhi-Heng Wang; Meng Sha; Lei Chen; Qiang Xia
Journal:  Hepatol Int       Date:  2018-06-26       Impact factor: 6.047

4.  Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.

Authors:  Zhen-Feng Wu; Xiao-Yu Wu; Nan Zhu; Zhe Xu; Wei-Su Li; Hai-Bin Zhang; Ning Yang; Xue-Quan Yao; Fu-Kun Liu; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

5.  Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.

Authors:  Xu-Feng Zhang; Jeffery Chakedis; Fabio Bagante; Eliza W Beal; Yi Lv; Matthew Weiss; Irinel Popescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

Review 6.  Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.

Authors:  Zheng Wang; Yuan-Yuan Sheng; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 7.  Hepatitis B virus infection and intrahepatic cholangiocarcinoma.

Authors:  Hua-Bang Zhou; Jing-Yi Hu; He-Ping Hu
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

Review 8.  HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature.

Authors:  Caixia Wang; Haiyan Jing; Dan Sha; Weibo Wang; Jianpeng Chen; Yangang Cui; Junqing Han
Journal:  BMC Infect Dis       Date:  2016-06-14       Impact factor: 3.090

Review 9.  HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis.

Authors:  Hao Zhang; Biqing Zhu; He Zhang; Jianxin Liang; Wenting Zeng
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

10.  Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection.

Authors:  Seogsong Jeong; Qingbao Cheng; Lifeng Huang; Jian Wang; Meng Sha; Ying Tong; Lei Xia; Longzhi Han; Zhifeng Xi; Jianjun Zhang; Xiaoni Kong; Jinyang Gu; Qiang Xia
Journal:  BMC Cancer       Date:  2017-07-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.